Bayer sues Novartis unit over generic YAZ

08/5/2008 | Bloomberg

Bayer filed suit against Sandoz, Novartis' generic-drug unit, to block the company from launching its version of YAZ, a blockbuster birth-control pill, in the U.S. Bayer also sued Sandoz and other generic-drug makers seeking approval to market copies of a related treatment, Yasmin, after losing a patent dispute with Barr Pharmaceuticals.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care